Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 303

1.

Nanotech-derived topical microbicides for HIV prevention: The road to clinical development.

Sánchez-Rodríguez J, Vacas-Córdoba E, Gómez R, De La Mata FJ, Muñoz-Fernández MA.

Antiviral Res. 2014 Nov 7;113C:33-48. doi: 10.1016/j.antiviral.2014.10.014. [Epub ahead of print] Review.

PMID:
25446339
[PubMed - as supplied by publisher]
2.

Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE Jr; PENPACT-1 (PENTA 9/PACTG 390) Study Team.

Pediatrics. 2014 Oct;134(4):e1104-16. doi: 10.1542/peds.2014-0527.

PMID:
25266426
[PubMed - in process]
3.

Use of carbosilane dendrimer to switch macrophage polarization for the acquisition of antitumor functions.

Perisé-Barrios AJ, Gómez R, Corbí AL, de la Mata J, Domínguez-Soto A, Muñoz-Fernandez MA.

Nanoscale. 2014 Sep 25. [Epub ahead of print]

PMID:
25254497
[PubMed - as supplied by publisher]
4.

IFNγ-TNFα-IL2-MIP1α-CD107a+PRF1+ CD8 pp65-Specific T-Cell Response Is Independently Associated With Time to Death in Elderly Humans.

Ferrando-Martínez S, Ruiz-Mateos E, Casazza JP, de Pablo-Bernal RS, Dominguez-Molina B, Muñoz-Fernández MA, Delgado J, de la Rosa R, Solana R, Koup RA, Leal M.

J Gerontol A Biol Sci Med Sci. 2014 Sep 18. pii: glu171. [Epub ahead of print]

PMID:
25238774
[PubMed - as supplied by publisher]
5.

HIV-1 induces B-cell activation and class switch recombination via spleen tyrosine kinase and c-Jun N-terminal kinase pathways.

Perisé-Barrios AJ, Correa-Rocha R, Alvarez S, Muñoz-Fernandez MA, Pion M.

AIDS. 2014 Oct 23;28(16):2365-74. doi: 10.1097/QAD.0000000000000442.

PMID:
25160932
[PubMed - in process]
6.

Enhanced activity of carbosilane dendrimers against HIV when combined with reverse transcriptase inhibitor drugs: searching for more potent microbicides.

Vacas-Córdoba E, Galán M, de la Mata FJ, Gómez R, Pion M, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2014 Jul 29;9:3591-600. doi: 10.2147/IJN.S62673. eCollection 2014.

PMID:
25114528
[PubMed - in process]
Free PMC Article
7.

Interference of cationic polymeric nanoparticles with clinical chemistry tests--clinical relevance.

Shcharbin D, Shcharbina N, Milowska K, de la Mata FJ, Muñoz-Fernandez MA, Mignani S, Gomez-Ramirez R, Majoral JP, Bryszewska M.

Int J Pharm. 2014 Oct 1;473(1-2):599-606. doi: 10.1016/j.ijpharm.2014.07.054. Epub 2014 Aug 1.

PMID:
25091374
[PubMed - in process]
8.

TNF-α levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects.

De Pablo-Bernal RS, Ruiz-Mateos E, Rosado I, Dominguez-Molina B, Alvarez-Ríos AI, Carrillo-Vico A, De La Rosa R, Delgado J, Muñoz-Fernández MA, Leal M, Ferrando-Martínez S.

J Antimicrob Chemother. 2014 Nov;69(11):3041-6. doi: 10.1093/jac/dku263. Epub 2014 Jul 9.

PMID:
25011654
[PubMed - in process]
9.

Reproductive desire in women with HIV infection in Spain, associated factors and motivations: a mixed-method study.

Hernando V, Alejos B, Álvarez D, Montero M, Pérez-Elías MJ, Blanco JR, Masiá M, Del Romero J, de los Santos I, Rio I, Llácer A; CoRIS.

BMC Pregnancy Childbirth. 2014 Jun 5;14:194. doi: 10.1186/1471-2393-14-194.

PMID:
24902487
[PubMed - in process]
Free PMC Article
10.

Expression of gut-homing β7 receptor on T cells: surrogate marker for microbial translocation in suppressed HIV-1-infected patients?

Abad-Fernández M, Gutiérrez C, Madrid N, Hernández-Novoa B, Díaz L, Muñoz-Fernández M, Moreno S, Vallejo A.

HIV Med. 2015 Jan;16(1):15-23. doi: 10.1111/hiv.12167. Epub 2014 May 15.

PMID:
24831847
[PubMed - in process]
11.

Determinants of highly active antiretroviral therapy duration in HIV-1-infected children and adolescents in Madrid, Spain, from 1996 to 2012.

Palladino C, Briz V, Bellón JM, Climent FJ, de Ory SJ, Mellado MJ, Navarro ML, Ramos JT, Taveira N, de José MI, Muñoz-Fernández MÁ; CoRISpeS-Madrid Cohort Working Group.

PLoS One. 2014 May 1;9(5):e96307. doi: 10.1371/journal.pone.0096307. eCollection 2014.

PMID:
24788034
[PubMed - in process]
Free PMC Article
12.

CCR5/CD4/CXCR4 oligomerization prevents HIV-1 gp120IIIB binding to the cell surface.

Martínez-Muñoz L, Barroso R, Dyrhaug SY, Navarro G, Lucas P, Soriano SF, Vega B, Costas C, Muñoz-Fernández MÁ, Santiago C, Rodríguez Frade JM, Franco R, Mellado M.

Proc Natl Acad Sci U S A. 2014 May 13;111(19):E1960-9. doi: 10.1073/pnas.1322887111. Epub 2014 Apr 28.

PMID:
24778234
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Functionally defective high-density lipoproteins are related to heightened T-cell activation in vertically HIV-infected adolescents.

Sainz T, Ortega-Hernández A, Serrano-Villar S, Navarro ML, Rojo P, Ramos JT, Mellado MJ, Diaz L, Alvarez M, Estrada V, Gómez-Garre D, Muñoz-Fernández MA; Madrid Cohort of HIV-infected children and adolescents, integrating the Pediatric branch of the National AIDS Research Network of Spain (CoRISpE).

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):265-9. doi: 10.1097/QAI.0000000000000160.

PMID:
24732875
[PubMed - in process]
14.

Synthesis of new anionic carbosilane dendrimers via thiol-ene chemistry and their antiviral behaviour.

Galán M, Sánchez Rodríguez J, Jiménez JL, Relloso M, Maly M, de la Mata FJ, Muñoz-Fernández MA, Gómez R.

Org Biomol Chem. 2014 May 28;12(20):3222-37. doi: 10.1039/c4ob00162a. Epub 2014 Apr 14.

PMID:
24728319
[PubMed - in process]
15.

Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection.

Perisé-Barrios AJ, Jiménez JL, Domínguez-Soto A, de la Mata FJ, Corbí AL, Gomez R, Muñoz-Fernandez MÁ.

J Control Release. 2014 Jun 28;184:51-7. doi: 10.1016/j.jconrel.2014.03.048. Epub 2014 Apr 8.

PMID:
24721235
[PubMed - in process]
16.

WNT Signaling Suppression in the Senescent Human Thymus.

Ferrando-Martínez S, Ruiz-Mateos E, Dudakov JA, Velardi E, Grillari J, Kreil DP, Muñoz-Fernandez MA, van den Brink MR, Leal M.

J Gerontol A Biol Sci Med Sci. 2014 Mar 30. [Epub ahead of print]

PMID:
24657825
[PubMed - as supplied by publisher]
17.

Maraviroc reduces the regulatory T-cell frequency in antiretroviral-naive HIV-infected subjects.

Pozo-Balado MM, Martínez-Bonet M, Rosado I, Ruiz-Mateos E, Méndez-Lagares G, Rodríguez-Méndez MM, Vidal F, Muñoz-Fernández MA, Pacheco YM, Leal M.

J Infect Dis. 2014 Sep 15;210(6):890-8. doi: 10.1093/infdis/jiu180. Epub 2014 Mar 20.

PMID:
24652492
[PubMed - indexed for MEDLINE]
18.

Clinically relevant transmitted drug resistance to first line antiretroviral drugs and implications for recommendations.

Monge S, Guillot V, Alvarez M, Chueca N, Stella N, Peña A, Delgado R, Córdoba J, Aguilera A, Vidal C, García F; CoRIS.

PLoS One. 2014 Mar 17;9(3):e90710. doi: 10.1371/journal.pone.0090710. eCollection 2014.

PMID:
24637804
[PubMed - in process]
Free PMC Article
19.

Prostaglandin E2 reduces the release and infectivity of new cell-free virions and cell-to-cell HIV-1 transfer.

Clemente MI, Álvarez S, Serramía MJ, Martínez-Bonet M, Muñoz-Fernández MÁ.

PLoS One. 2014 Feb 25;9(2):e85230. doi: 10.1371/journal.pone.0085230. eCollection 2014.

PMID:
24586238
[PubMed - in process]
Free PMC Article
20.

Amphiphilic cationic carbosilane-PEG dendrimers: synthesis and applications in gene therapy.

Sánchez-Nieves J, Fransen P, Pulido D, Lorente R, Muñoz-Fernández MÁ, Albericio F, Royo M, Gómez R, de la Mata FJ.

Eur J Med Chem. 2014 Apr 9;76:43-52. doi: 10.1016/j.ejmech.2014.01.061. Epub 2014 Jan 31.

PMID:
24565572
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk